China’s government-supported researchers have developed a quantum computing pipeline that could revolutionize drug discovery. This pipeline combines simulations and calculations to address complex drug design challenges, such as drug-target interactions and bond energy, moving quantum computing from theoretical models to practical applications.
Despite promising results, the technology still faces hurdles, including high computational costs and long processing times. The government plays a crucial role in advancing these digital innovations, which aim to improve drug safety and efficacy, potentially leading to significant breakthroughs in pharmaceuticals and enhancing global health outcomes.
